Opioid Prescribing in the Emergency Department for Sickle Cell Disease
NCT06835335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1063
Last updated 2026-01-23
Summary
This study consists of a clinical vignette presented to emergency physicians asking them what they would prescribe to a patient with acute abdominal pain.
Conditions
- Discrimination, Racial
- Pain Management
- Emergency Medicine
- Sickle Cell Disease
Interventions
- BEHAVIORAL
-
opioid prescription
The intervention consisted of a randomized questionnaire presenting a clinical case of a patient suffering from severe abdominal pain. The control case was "As an emergency physician in an adult emergency department, you are presented with the following patient: The patient is a 39-year-old non-smoking male/female with a history of Meniere's disease and an allergy to Bactrim. He/she presents with abdominal pain that began abruptly 2 hours ago and has persisted despite taking NEFOPAM 45 minutes ago. This is his first episode. His/her vital signs are blood pressure 140/66, heart rate 91, pulse ox 97%, temperature 36.8°C. He/she rates his/her pain as 8/10 without any analgesic position. On clinical examination he/she presents with localized epigastric tenderness. The rest of the abdomen is soft, painless and depressed. There are hydro-aeriform noises. No diarrhea or vomiting. The rest of the clinical examination showed no abnormalities.". In the intervention case, patient had history of S
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-17
- Primary Completion
- 2025-03-19
- Completion
- 2025-03-19
Countries
- France
- United Kingdom
Study Locations
More Related Trials
-
Program for Pain & Prescription Opioid Use in Pregnancy
NCT02804152 ·Status: COMPLETED ·Phase: NA
-
International Prospective Study on Morphine-induced Adverse Drug Reactions in Emergency Departments.
NCT01654055 ·Status: COMPLETED
-
Attention and Memory Disorders Related to Acute Morphine
NCT03507985 ·Status: UNKNOWN
-
Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally
NCT01380197 ·Status: COMPLETED ·Phase: PHASE3
-
The Experiences of People Prescribed Opioid Pain Medicines
NCT04888897 ·Status: COMPLETED
-
Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
NCT00685295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
NCT02299024 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
NCT00343733 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia
NCT03236805 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
NCT00214955 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
NCT01428583 ·Status: COMPLETED ·Phase: PHASE3
-
Herb-Opioid Interactions
NCT00027014 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain
NCT00214942 ·Status: COMPLETED ·Phase: PHASE3
-
Variation in Opioid Prescribing and Use for Acute Pain in Diverse Populations
NCT04509115 ·Status: COMPLETED
-
Oxycodone Concentration in the Blood After Oral Premedication
NCT03386318 ·Status: COMPLETED
-
A Study to Investigate of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle
NCT05856136 ·Status: RECRUITING ·Phase: PHASE4
-
Monitoring Side Effects Of Pain Medication Prescribing By Emergency Department In Patients Over 65
NCT02046681 ·Status: COMPLETED
-
Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
NCT00228605 ·Status: COMPLETED ·Phase: PHASE3
-
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
NCT00246532 ·Status: COMPLETED ·Phase: PHASE4
-
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
NCT01688583 ·Status: COMPLETED
-
Comparison of Standard Opioid Prescription Versus Prescription Guided by Pharmacogenetic Analysis in Patients With Non-cancerous Chronic Pain.
NCT03498014 ·Status: WITHDRAWN ·Phase: NA
-
Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease
NCT02222246 ·Status: COMPLETED ·Phase: PHASE4
-
Prescription Medication Interactions
NCT04315181 ·Status: COMPLETED ·Phase: PHASE1
-
Pre-hospital Morphine Titration : Comparison of 0,05 Versus 0,1 mg/kg
NCT00237731 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain
NCT05037539 ·Status: COMPLETED ·Phase: PHASE1/PHASE2